Presentation slides and video from the 2018 Advances in Cancer Immunotherapy™ - Durham, NC held on February 9, 2018 are available here.Program Organizers
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part B: Immune-Related Adverse Even (irAE) Management; Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Michael A. Morse, MD - Duke University Medical Center; Date: February 9, 201800:29:53
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: Neal E. Ready, MD, PhD - Duke University Medical Center; Date: February 9, 201800:29:27
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice: Presentation: Effective Practices for Incorporating Immunotherapy into Hospital Operations; Presenter: Sanjiv S. Agarwala, MD - St. Luke's Cancer Center and Temple University; Date: February 9, 201800:25:50
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part B: Immune-Related Adverse Even (irAE) Management; Presentation: Mechanisms of Immune-Related Adverse Events; Presenter: Michael A. Morse, MD - Duke University Medical Center; Date: February 9, 201800:27:09
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part B: Immune-Related Adverse Even (irAE) Management; Presentation: Identification and MAnagement of irAEs in the Emergency Setting; Presenter: Leslie Zun, MD - Chicago Medical School; Date: February 9, 201800:26:50
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Basic Principles of Cancer Immunotherapy; Presenter: Zachary Hartman, PhD - Duke University Medical Center; Date: February 9, 201800:27:29
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part B: Immune-Related Adverse Even (irAE) Management; Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring and Management; Presenter: Kate Kalinowski, RN, MSN - Duke University Medical Center; Date: February 9, 201800:23:53
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Brent A. Hanks, MD, PhD - Duke University Medical Center; Date: February 9, 201800:21:37
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Genitourinary Cancers ; Presenter: Brant A. Inman, MD, MS - Duke University Medical Center; Date: February 9, 201800:18:41
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice: Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Amy Schippers, PA-C - St. Luke's University & Health Network and St. Luke's Cancer Center; Date: February 9, 201800:18:39
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: David A. Rizzieri, MD - Duke University Medical Center; Date: February 9, 201800:19:41
Meeting: Advances in Cancer Immunotherapy™- Durham, NC; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Edward S. Kim, MD, FACP - Levine Cancer Institute, Carolinas HealthCare System; Date: February 9, 201800:17:26
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us